Visiongain Report Analyses Leading Payers within the $173bn Oncology Drugs Market

- Top 30 Oncology Drugs Manufacturers 2019

- AstraZeneca, Merck, Novartis, Amgen, GlaxoSmithKline, Johnson & Johnson, Roche, Pfizer, Eli Lilly, Other Companies

LONDON, July 5, 2019 /PRNewswire/ -- Cancer treating drugs market forms the most lucrative sector in pharmaceuticals. As the ageing population continues to rise across the world, the incidence of cancer will continue to grow, leading to increased spending on cancer-treating medicines. This report lists and discusses the top 30 oncology drugs manufacturers.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 157-page report you will receive 83 tables and 64 figures–all unavailable elsewhere.

The 157-page report provides clear detailed insight into the top 30 oncology drugs manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading Visiongain's brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/top-30-oncology-drugs-manufacturers-2019/#download_sampe_div

Report Scope

• Assessment of the leading companies in the global oncology drugs market. The list below shows some of the companies that are discussed in the report:
• Abbott Laboratories
• AbbVie
• Amgen
• Astellas Pharma
• AstraZeneca
• Aurora Biophama
• Boehringer Ingelheim
• Bristol-Myers Squibb (BMS)
• Celgene Corporation
• Eli Lilly
• Fresenius Kabi
• Gilead
• GlaxoSmithKline (GSK)
• Grifols
• Johnson & Johnson
• Jounce Therapeutics
• Other companies

• For each company, the report provides information and discussion on:
• Company overview
• Product portfolio
• Recent development
• Financial information

• Key questions answered by this report:
• How is the Oncology Drugs Manufacturers market evolving?
• What is driving and restraining the Oncology Drugs Manufacturers market?
• What will be the main driver for the overall market?
• Will leading Oncology Drugs Manufacturers broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• Who are the leading players and what are their prospects over the forecast period?

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/top-30-oncology-drugs-manufacturers-2019/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

Abbott Laboratories, Inc.
AbbVie
Ablynx NV
Agios Pharmaceuticals, Inc.
Alcon
Allergan plc.
Allogene Therapeutics, Inc.
Amgen
ARMO BioSciences, Inc.
Astellas Pharma Inc.
AstraZeneca
AurKa Pharma, Inc.
Aurora Biopharma, Inc.
Bavarian Nordic
BeiGene
BiolineRX
BioNTech AG.
Biothera
Bristol-Myers Squibb
Boehringer Ingelheim
Calibr
Calico
Calithera Biosciences
Celgene Corporation
Celgene International Sarl
Ciba-Geigy
CytomX Therapeutics
Eisai Co., Ltd.
Eli Lilly
Flatiron Health
Flexus Biosciences, Inc.
Fosun Pharma
Foundation Medicine, Inc.
Fresenius Kabi AG
Genscript Biotech Corporation
Gilead Science
GlaxoSmithKline (GSK)
Harpoon Therapeutics
Heptares Therapeutics
IBM
IBM Watson
IFM Therapeutics
Ignyta
Immatics Biotechnologies
Janssen Diagnostics, LLC.
Johnson & Johnson
Jounce Therapeutics, Inc.
Juno Therapeutics, Inc.
Kimberly-Clark Corporation
Kite Pharma
Legend Biotech Ireland Limited
Legend Biotech USA Inc.
MD Anderson
MedImmune
Menarini Industrie Farmaceutiche Riunite Srl
Merck & Co.
Miltenyi Biotec
Moderna Therapeutics
Mylan N.V.
Nektar Therapeutics
Noile-Immune Biotech
Novartis
Ono Pharmaceutical Company
OSE
Parker Institute
Pfizer
Regeneron Pharmaceuticals, Inc
Rigontec
Roche
Sandoz
Sangamo Therapeutics
SARAH CANNON Research Institute
SCILEX
Selvita
Simcere
Sorrento Therapeutics, Inc.
Sosei Group Corporation
Sun Pharmaceutical Industries Ltd.
Takeda
TerSera Therapeutics LLC
Tessa Therapeutics Pte Ltd.
Valeant Phamaceuticals International, Inc.
Veropharm
Vyriad
ZIOPHARM Oncology, Inc.

List of Organizations Mentioned in the Report
European Commission
European Medicines Agency
Food and Drug Administration (FDA)
Health Canada
Japan's Pharmaceuticals and Medical Devices Agency (PMDA)
Japanese Ministry of Health, Labour and Welfare
Johns Hopkins
World Child Cancer
World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Related reports:

Global Blood Cancer Market Forecast to 2028

Global Biosimilars and Follow-On Biologics Market 2019-2029

Global Cancer Immunotherapy Market Forecast 2019-2029

Biologics Market Trends and Forecasts 2018-2028

Global Next-Generation Antibody Therapies Market Forecast 2018-2028

Global Acute Myeloid Leukaemia Market Forecast 2018-2028